A recent study reveals a dramatic increase in the number of young Australians prescribed medication for attention-deficit hyperactivity disorder (ADHD), with figures soaring more than tenfold over the past two decades. Interestingly, the trends have shifted, indicating that children from affluent backgrounds are now more likely to receive these prescriptions, a stark contrast to previous patterns that favoured those from lower socioeconomic areas.
A Closer Look at ADHD Trends
ADHD stands as the most frequently diagnosed disorder among children in Australia, manifesting through behaviours that can disrupt daily life, whether at home, school, or work. The primary treatment method involves the use of psychostimulant drugs, which have seen a significant uptick in prescriptions in recent years.
Our research team meticulously analysed two decades of national data, spanning from 2003 to 2022, sourcing official prescription records from Australia’s Pharmaceutical Benefits Scheme (PBS). The objective was to track how prescription rates evolved across different states and territories, while also assessing the impact of socioeconomic status on access to medication.
The Numbers Speak Volumes
Between 2003 and 2022, the number of children aged 5 to 17 receiving ADHD medication escalated from 20,147 (0.5% of the youth population) to a staggering 246,021 (4.2%). The most notable increase occurred during the COVID-19 pandemic, with prescriptions for older teens (aged 15-17) rising from 3.1% in 2020 to 5.2% in 2022. This surge may be attributed to the lockdowns, which prompted families to seek assistance for neurodivergent conditions.
Two decades ago, prescription rates varied significantly based on geography and family income. Regions like Queensland and Western Australia frequently recorded higher prescribing rates, particularly in Western Australia and Tasmania. However, as our analysis indicates, these discrepancies have narrowed, suggesting a move towards more uniform diagnostic and treatment practices across the nation.
Wealth and Prescription Patterns: A Shift in Dynamics
Historically, children in disadvantaged areas were more likely to receive ADHD medications. This trend has now inverted, with children from wealthier regions—specifically, the top 10% of affluent postcodes—leading the way in prescription rates. In 2003, affluent areas had a lower prescription ratio of 0.612. Fast forward to 2021, and that figure skyrocketed to 1.245, placing them at the forefront of ADHD medication prescriptions.
The shift is likely linked to improved access to healthcare and a growing societal awareness of ADHD. In the past, families in lower-income brackets might have faced obstacles in obtaining diagnoses and treatment, often contending with long wait times and limited resources. That said, today’s data indicates that most postcodes now align closely with the national average, highlighting a significant reduction in the previously observed “postcode lottery” effect regarding treatment access.
Limitations of the Study
While our study provides valuable insights, it is essential to recognise its limitations. The data exclusively includes prescriptions filled through the PBS, thus omitting those from the private medical sector, which could further elevate the trend in wealthier areas. Additionally, factors such as cultural or ethnic influences remain unaddressed due to the anonymous nature of the data collection. Although diagnostic guidelines have evolved, particularly with ADHD and autism diagnoses being allowed since 2013, no immediate surge in prescriptions was noted, reinforcing the gradual increase observed since 2020.
Why it Matters
The findings from this research highlight a growing acceptance of ADHD and a commitment to supporting affected children, signalling a shift towards better understanding and treatment of neurodivergence in Australia. While the end of the “postcode lottery” in ADHD treatment is encouraging, the stark rise in prescriptions among wealthier families calls for continued scrutiny regarding access and equity in healthcare. It underscores the necessity for ongoing efforts to ensure that all children, regardless of their socio-economic background, can receive appropriate support and care.